lobbying_activities: 2828116

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2828116	b96a3ebf-019a-43ef-8599-ee20ee082b47	Q2	BURRELL INTERNATIONAL GROUP LLC	401103483	ACER THERAPEUTICS	2022	second_quarter	PHA	COVID 19 therapeutics and Medical Countermeasures, Rare Disease and Re-purposed drugs; - FY22 Defense Appropriations for MCM Development	HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2022-07-19T10:10:47-04:00